Pharma Journalist - Page 669 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Pharmaceutics International Receives EIR from FDA

BioArctic Announces Start of Phase 1 Study of ABBV-0805 for Parkinson’s Disease

Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca

Deerfield commits $100M to create alliance with Harvard

Hoth Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene

Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine

Agenus Milestone Triggers $7.5M Payment from Gilead

X4 Pharmaceuticals Completes Merger with Arsanis

FDA Approves Dupixent (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents

Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial